Drug Discovery in Regenerative Medicine – a Case Study
Learn how Dr. Paul Tesar and colleagues, at the Case Western Reserve University School of Medicine in Cleveland, rapidly identified promising molecules for multiple sclerosis therapy.
Summary |
In this case study, learn how:
- The phenotypic screening assay was set up on the Operetta® high-content analysis system.
- Complex phenotypic changes, such as differentiation of oligodendrocytes, can be reliably quantified.
- High-content screening, combined with cutting-edge stem cell technology, plays a key role in drug discovery within regenerative medicine
|